NONMEM Users Network Archive

Hosted by Cognigen

Re: cumulative AUC

From: Leonid Gibiansky <lgibiansky>
Date: Fri, 8 Nov 2019 13:58:01 -0500

actually CMT=-4 turns compartment 4 off. It need to be turned on again,
see by the record with CMT=4 (positive), see

Plasma urine example

in Nonmem help


On 11/8/2019 1:47 PM, Leonid Gibiansky wrote:
> Negative CMT (in the data set) resets compartment amounts (CMT=-4 in
> this case)
> EVID = 4 resets all system, including A(4)  (if washout time was long
> and all compartments can be set to 0)
> Also, it is easy to do post-processing, subtracting Cycle 1 AUC from
> Cycle 1-2 AUC to get Cycle 2 AUC, etc.
> Hope this helps
> Leonid
> On 11/8/2019 12:59 PM, Sam Liao wrote:
>> Dear nmusers,
>> I have a question how to reset cumulative AUC in a $DES model, where
>> DADT(4) is set up as cumulative AUC of C1.
>> Because the study is a four way crossover study, the cumulative value
>> of A(4) need to rest to zero before each subsequent treatments.
>> However, NONMEM do not allow setting A(4) to zero in the statement of
>> control stream.
>> Is there any work around of this problem?
>> Best regards,
>> Sam Liao
>> On 11/7/2019 7:17 AM, Farrell, Colm wrote:
>>> At ICON, it’s our people that set us apart.
>>> As a global provider of drug development solutions, our work is
>>> serious business. But that doesn’t mean you can’t have fun while you
>>> do it. With our vision to be the partner of choice in drug
>>> development, we hire only the best and brightest in the industry. Are
>>> you one of them?
>>> Due to the continuing demand to support our clients in drug
>>> development through the integration of modelling and simulation into
>>> clinical development programs, ICON is looking for an experienced
>>> pharmacometrician to join our global PKPDM&S team, with a key
>>> responsibility to develop and apply M&S strategies, study designs and
>>> analyses across all phases of drug development.  With members of the
>>> PKPDM&S based in UK and USA, we’re flexible on the location.
>>> *The role*
>>> ·Prepare PKPDM&S-based strategies to support clinical development
>>> programs;
>>> ·Design, conduct, interpret and prepare appropriate study and
>>> regulatory summaries of PKPDM&S activities;
>>> ·Build and sustain great relationships with clients;
>>> ·Prepare and present scientific publications;
>>> ·Serve as scientific reviewer and staff mentor to colleagues.
>>> *What you need*
>>> ·PhD (or equivalent experience) in pharmacokinetics/PKPD with proven
>>> industry or academic post PhD experience;
>>> ·Excellent understanding of the integration of PKPDM&S into clinical
>>> drug development
>>> ·Demonstrated expertise in hands-on population-based modelling e.g.
>>> NONMEM, Monolix and related software (R, Xpose, PsN);
>>> ·Proven mentorship capabilities.
>>> *Why join us*
>>> ICON enjoys a strong reputation for quality and is focused on staff
>>> development. We make it our mission to attract the most diverse and
>>> creative minds into the business and we continually strive to provide
>>> opportunities for our people to excel, grow and build a phenomenal
>>> career. We understand that our greatest asset is the skills and
>>> talents of our people and they are truly what set us apart. Other
>>> than working with a great team of switched on and ambitious people,
>>> we also offer a very competitive benefits package. This varies from
>>> country to country so a dedicated recruiter will discuss this with
>>> you at interview stage. We care about our people as they are the key
>>> to our success. We provide an open and friendly work environment
>>> where we empower people and provide them with opportunities to
>>> develop their long term career. ICON is an equal opportunity employer
>>> - M/F/D/V and committed to providing a workplace free of any
>>> discrimination or harassment.
>>> To find out more and apply for the role, please visit:
>>> ICON plc made the following annotations.
>>> ------------------------------------------------------------------------------
>>> This e-mail transmission may contain confidential or legally
>>> privileged information that is intended only for the individual or
>>> entity named in the e-mail address. If you are not the intended
>>> recipient, you are hereby notified that any disclosure, copying,
>>> distribution, or reliance upon the contents of this e-mail is
>>> strictly prohibited. If you have received this e-mail transmission in
>>> error, please reply to the sender, so that ICON plc can arrange for
>>> proper delivery, and then please delete the message.
>>> Thank You,
>>> ICON plc
>>> South County Business Park
>>> Leopardstown
>>> Dublin 18
>>> Ireland
>>> Registered number: 145835
>> --
>> Sam Liao
Received on Fri Nov 08 2019 - 13:58:01 EST

The NONMEM Users Network is maintained by ICON plc. Requests to subscribe to the network should be sent to:

Once subscribed, you may contribute to the discussion by emailing: